Morphine Extended-Release Capsules and Rescula Ophthalmic Solution
Determining the interaction of Morphine Extended-Release Capsules and Rescula Ophthalmic Solution and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
Generic Name: unoprostone ophthalmic
Brand name: Rescula
Synonyms: Rescula
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Morphine Extended-Release Capsules-Resectisol
- Morphine Extended-Release Capsules-Reserpine
- Morphine Extended-Release Capsules-Reserpine, hydralazine, and hydrochlorothiazide
- Morphine Extended-Release Capsules-Resinol topical
- Morphine Extended-Release Capsules-Resorcinol and sulfur Topical
- Morphine Extended-Release Capsules-Resorcinol topical
- Rescula Ophthalmic Solution-Morphine Immediate-Release Tablets and Capsules
- Rescula Ophthalmic Solution-Morphine injection
- Rescula Ophthalmic Solution-Morphine Injection PF
- Rescula Ophthalmic Solution-Morphine Long-Acting Tablets
- Rescula Ophthalmic Solution-Morphine Oral Concentrate (20 mg/mL)
- Rescula Ophthalmic Solution-Morphine Oral Solution